SureTrader
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTB)

ENTB RSS Feed
Add ENTB Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator gotinearly, ronrooster, sizzleweed, Kbro13
Search This Board:
Last Post: 7/4/2015 8:47:14 AM - Followers: 458 - Board type: Free - Posts Today: 2

 

 

http://www.entb.net


 

 

 

 

 

Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328
E-mail:
info@EntestBio.com

Web site: www.EntestBio.com

 

CIK 0001449447
 

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


 

In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)
 


Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.

 

Management: 

David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance



 

http://www.entb.net
 

 Recent News!

June 1, 2015

 http://www.marketwired.com/press-release/entest-biomedical-inc-discussions-acquire-nanotechnology-delivery-system-cancer-therapy-otc-pink-entb-2025182.htm

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTB
Current Price
Volume:
Bid Ask Day's Range
Wiki
ENTB News: Current Report Filing (8-k) 06/26/2015 06:15:40 AM
ENTB News: Current Report Filing (8-k) 05/22/2015 09:13:17 AM
ENTB News: Quarterly Report (10-q) 04/10/2015 09:12:35 AM
ENTB News: Quarterly Report (10-q) 01/13/2015 06:03:03 AM
PostSubject
#36935  Sticky Note Today news COINSTRADERS 06/01/15 11:10:29 AM
#37097   Koos NEEDS another DILUTIVE SHARE SELLING WELFARE ATM! SCAMDOOFUS angelicsatan666 07/04/15 08:47:14 AM
#37096   IMO This R/S will coinside with the Zander sizzleweed 07/04/15 02:44:58 AM
#37095   I just verified the information.check it out for yourself.http://nvsos.gov/sosen ronrooster 07/03/15 10:36:58 PM
#37094   When I first got involved with ENTB it Brakeman 07/03/15 07:27:19 PM
#37093   My question is this, ctvette2003 07/03/15 06:32:53 PM
#37092   Somebody is a smart cookie. Shotime66 07/03/15 02:23:24 PM
#37091   Thanks jokers.Been holding for over a year now, stokjunky 07/03/15 11:50:49 AM
#37090   Stokjunky, there is not a statement, that will JokersWild12 07/03/15 11:20:53 AM
#37089   ENTB's a/s will go from current 6b to ronrooster 07/03/15 11:06:14 AM
#37088   It appears only insiders know that information about Brakeman 07/03/15 10:25:50 AM
#37087   I bet Siz is happy now since you Brakeman 07/03/15 07:32:49 AM
#37086   Where does it say anything about a 12 stokjunky 07/03/15 07:25:56 AM
#37085   Your Loss Is Our Gain. BlackDragons 07/03/15 12:17:44 AM
#37084   If this is the only update of our sante1 07/02/15 11:18:20 PM
#37083   1 for 12 is a very small rs prof81 07/02/15 09:08:17 PM
#37082   Looks to be a 1 for 12 split. JokersWild12 07/02/15 06:32:12 PM
#37081   It is as inevitable as DEATH! stallion70 07/02/15 06:13:53 PM
#37080   Reverse split coming up: LeGoose 07/02/15 03:23:06 PM
#37079   Wow, all this hype for nothing. This POS stallion70 07/01/15 03:32:08 PM
#37078   Board affiliations for Entest barbeszoo 06/29/15 07:51:01 AM
#37077   ENTB about ready to rock? Looks like Dr Lewisinhk 06/29/15 02:03:09 AM
#37076   Who knows, but I smell pennies. No wonder sizzleweed 06/27/15 06:29:54 PM
#37075   2-5? Can I have some of what your ctvette2003 06/26/15 07:48:04 PM
#37074   I'm looking forward to 2 cents to 5 panda11 06/26/15 07:09:41 PM
#37073   Here some Friday afternoon SPECULATION. ronrooster 06/26/15 02:51:35 PM
#37072   RE ZANDER http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=P9BeF1g1K40 ronrooster 06/26/15 02:25:23 PM
#37071   Probably not barbeszoo 06/26/15 09:58:55 AM
#37070   http://www.zoominfo.com/p/Chris-Zander/-2106004133 barbeszoo 06/26/15 09:57:04 AM
#37069   Wonder if this has any connection to Zander barbeszoo 06/26/15 09:50:03 AM
#37068   Interesting how this news will play out for entb. firehousestocks 06/26/15 09:28:47 AM
#37067   Spin off? ctvette2003 06/26/15 07:50:42 AM
#37066   5's up! Kbro13 06/25/15 03:17:02 PM
#37065   hmmm i think baby sister is ripe she's jhenmal 06/25/15 10:33:22 AM
#37064   This volume so early is, IMO, an indication bucks2pennies 06/25/15 09:55:58 AM
#37063   4's falling. Kbro13 06/25/15 09:34:22 AM
#37062   Than I guess it would be time to vegasdrummer 06/23/15 12:14:51 PM
#37061   No news - No volume - back to 0.0001 COINSTRADERS 06/23/15 08:24:36 AM
#37059   To much volume here COINSTRADERS 06/22/15 10:27:59 AM
#37058   We should see LOI soon.Company would not release ronrooster 06/19/15 10:50:04 AM
#37057   To early we need another 2 years before COINSTRADERS 06/19/15 10:39:36 AM
#37056   Ha ha you were right! I gave myself sizzleweed 06/18/15 10:35:34 PM
#37055   no problem, just jumped on the sizzles wagon gotinearly 06/18/15 03:31:30 PM
#37054   Haha - oops. Welcome gotinearly. Kbro13 06/18/15 03:29:39 PM
#37053   Thanks sizzle gotinearly 06/18/15 03:23:33 PM
#37052   Thank you Kbro13! Welcome Gotinearly. ENTB is moving sizzleweed 06/18/15 03:22:34 PM
#37051   Is this not the same news that came ronrooster 06/18/15 01:28:57 PM
#37050   News out Entest BioMedical, Inc. in Discussions to COINSTRADERS 06/18/15 12:34:11 PM
#37049   Great addition! Kbro13 06/18/15 07:54:10 AM
#37048   No one selling at .0003 except the guy sizzleweed 06/18/15 12:01:48 AM
#37047   No one sell at 0.0003 ? COINSTRADERS 06/17/15 01:54:20 PM
PostSubject